2021 annual financial data

Sutro Biopharma 2021 Financial results

Sutro Biopharma 2021 financial results with verified reported values.

Direct answer

Revenue was 61,880,000 USD.

Operating income was -98,524,000 USD and net income was -105,538,000 USD.
Operating cash flow was -81,679,000 USD.

Get free Sutro Biopharma email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
61,880,000 USD
Operating income
-98,524,000 USD
Net income
-105,538,000 USD
Operating cash flow
-81,679,000 USD